… Heme oxygenase-1 (HO-1) is believed to represent a key … all known forms of anticancer
treatment, we have investigated … behavior and resistance to anticancer treatment were tested. …

Heme oxygenase-1 (HO-1) is an inducible enzyme that catalyzes oxidative degradation of
heme to form biliverdin, carbon monoxide (CO), and free iron. Biliverdin is subsequently …

… treatment. Consequently, HO-1 can be proposed as a therapeutic target for anticancer treatment
in … In summary, HO-1 inhibition might be the valuable anticancer approach, however, the …

… Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to
anticancer treatment. Clin Cancer Res 2005; 11: 3790-8. [77] Marinissen MJ, Tanos T, Bolos M, …

… between HMOX1 level and susceptibility to anti-cancer treatment, we have focused on …
prostate cancer were published showing both pro- and anti-cancer effect of HO-1 [27,28] we …

… to all current anticancer therapies. The cytoprotective enzyme heme oxygenase-1 (HO-1) is
… to play an important role in cancer resistance to anticancer treatment. The inhibition of HO-1 …

Heme oxygenase (HO)-1 is known to metabolize heme into biliverdin/bilirubin, carbon
monoxide, and ferrous iron, and it has been suggested to demonstrate cytoprotective effects …

Heme oxygenase-1 (HO-1) is a rate-limiting enzyme catalyzing oxidative degradation of
cellular heme to liberate free iron, carbon monoxide (CO) and biliverdin in mammalian cells. In …

… In this study we showed that ATO induced cell damage and heme oxygenase-1 (HO-1)
expression in glioma cells via ROS generation. HO-1 inducer clearly protected from ATO-induced …

… stress-response proteins, especially heme oxygenase-1 (HO-1). … advantage and survival of
anticancer treatment. Therefore, Nrf2 … /resistance to anticancer treatments, and metastasis or …